Clinical Trials Logo

Clinical Trial Summary

The purpose of this 12-week, prospective study is to determine the effects of oral supplementation with AyuFlex® (an over-the-counter dietary supplement) on joint mobility, joint comfort and functional capacity in healthy overweight subjects.


Clinical Trial Description

This interventional study is a 12-week, randomized, double-blind, placebo and dose-response controlled clinical trial (in 3 parallel groups) of male and female subjects without active osteoarthritis of the knee to be recruited at a single investigational center in the U.S. A two-week placebo lead-in period will precede the study to enhance statistical power. One-hundred and five (105) overweight, apparently healthy subjects, pre-screened using health history questionnaires, vital signs, blood work and a standardized lower extremity exercise performance test will be randomized to one of three groups for 84 days: placebo, AyuFlex1 (500 mg/d) or AyuFlex2 (1000 mg/d). AyuFlex is an organic, non-GMO, over-the-counter joint health product derived from the edible fruits of Terminalia chebula. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02589249
Study type Interventional
Source The Center for Applied Health Sciences, LLC
Contact
Status Completed
Phase N/A
Start date November 2015
Completion date February 7, 2017

See also
  Status Clinical Trial Phase
Completed NCT03802578 - The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients N/A
Completed NCT01896050 - Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer N/A
Recruiting NCT04354649 - Immune-Mediated Pathophysiology And Clinical Triage Program Phase 2
Terminated NCT00973141 - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain Phase 2
Recruiting NCT05564182 - High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain N/A
Recruiting NCT05033613 - Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
Recruiting NCT03953157 - Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors N/A
Not yet recruiting NCT06001125 - Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1) Phase 2
Terminated NCT02947022 - Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease Phase 1/Phase 2
Terminated NCT02047851 - Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis N/A
Withdrawn NCT01612728 - Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer Phase 2
Completed NCT02118636 - Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms N/A
Completed NCT00416715 - Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer Phase 2
Completed NCT00361582 - A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery Phase 3
Completed NCT02831582 - Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer N/A
Recruiting NCT04494412 - An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection Phase 2
Not yet recruiting NCT06134050 - Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy N/A
Completed NCT02778906 - Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia Phase 3
Terminated NCT01096407 - Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel Phase 1
Terminated NCT04164563 - Even-Up to Minimize Secondary Site Pain For Ankle Fracture N/A